Consequently, these data suggest that a dual inhibition strategy in which both AZIN1 and polyamine endocytosis are targeted simultaneously might be a novel approach to be considered in MYC amplified tumor subgroups (Fig. 6). Here, AZIN1 is linked to neoplasm.